Zulia is a state located in the northwest of Venezuela. Congenital malformations, deformities and chromosomal anomalies are the second cause of infant and neonatal mortality. There are seven public and private groups providing genetic services, the most important of which, the Medical Genetic Unit at the Zulia University was created in 1973. So far, this unit has provided genetic services to 12,000 families, and has been responsible for undergraduate and postgraduate education in human and medical genetics. Prenatal diagnosis is performed at the Unit and a private practice group, the most frequent referral reason being advanced maternal age. The most frequent genetic diseases in the state are Huntington’s disease, sickle cell anemia, neural tube defects and Down’s syndrome. Research in genetics includes the clinical, epidemiological and molecular characterization of hereditary diseases, cancer, reproductive problems and genetic diversity. Other public groups are conducting research on dementias, including Alzheimer’s disease, and on the genotoxic effects of environmental pollutants.

Keywords:
Medical genetics, Venezuela, Zulia
1.
Diagnosis of the situation of the childhood and the adolescence in the Zulia State. 2002, February. http://www.forosocialdelainfancia.org.ve.
2.
National Institute of Statistics. XIII General Census of population and housing. First results. 2003, January 23. http://ine.gov.ve/ine/indexine.asp.
3.
Pan American Health Organization. Country Health Profiles: Venezuela 2002. June 25, 2003. http://www.newweb.paho.org.
4.
Ministry of Health and Social Welfare. Health care establishment. Zulia 2000. http://www.msds.gov.ve.
5.
Ministry of Health and Social Welfare: Regional Direction of Epidemiology. Statistics of Health. Zulia State 2001. Ministry of Health and Social Welfare Publication No 4, 2002.
6.
Castilla EE, Orioli IM: ECLAMC: The Latin-American Collaborative Study of Congenital Malformations. Community Genet 2004;7:76–94.
7.
González-Ferrer S, Pineda-Del Villar L, Brito-Brito J, Prieto-Carrasquero M, Rojas-Atencio A, Angarita-Ávila L, et al: Hereditary diseases and congenital malformations at the Unit of Medical Genetics of the University of Zulia. Years: 1983–1992 (in Spanish). Invest Clin 1995;36:47–60.
8.
Prieto-Carrasquero M, Molero A, Carrasquero N, Paz V, González S, Pineda L, et al: Prenatal diagnosis. I: Prenatal diagnosis program at the Medical Genetics Unit of the Universidad de Zulia, Maracaibo, Venezuela (in Spanish). Invest Clin 1998;39:97–116.
9.
Bolivarian Republic of Venezuela Constitution. 1999. Official Gazette No. 5453. Caracas, 2000.
10.
Penal Code. October 20, 2000. www.worldlii.org/catalog/52011.html.
11.
Wexler NS, Young A, Tanzi R, Travers H, Starosta-Rubinstein S, Penney JB, et al: Homozygotes for Huntington’s disease. Nature 1987;326:194–197.
12.
Pineda L, Borjas L: Hemoglobinopathy S in the Toas Island: A genetic problem of public health (in Spanish). Invest Clin 1986;27:5–14.
13.
Pineda L, Villalobos H, Barrai I: The origin of the HbS gene in the Toas Island, Venezuela. Int J Anthropol 1988;3:1–8.
14.
Pineda L, Navarro G, Del Villar A: Neural tube defects at the Pedro García Clara Hospital, Zulia State, Venezuela (in Spanish). Invest Clin 1993;34:41–52.
15.
Soto-Quintana M, Alvarez-Nava F, Rojas-Atencio A, Granadillo V, Fernández D, Ocando A, et al: Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down’s syndrome patients (in Spanish). Invest Clin 2003;44:51–60.
16.
Rojas-Atencio A, Urdaneta K, Estrada P, Soto-Álvarez M, Borjas-Fajardo L, Boscan A, et al: Clonal chromosomal anomalies in colorectal tumors (in Spanish). Invest Clin 2002;43:263–270.
17.
Rojas A, Pineda L, González S, Soto M, Ávila E, Urdaneta B, et al: Chromosomal abnormalities in malignant hematologic diseases (in Spanish). Acta Cient Venez 2000;51:109–114.
18.
Álvarez-Nava F, Soto M, Borjas L, Ortiz R, Rojas A, Martínez S, et al: Molecular analysis of SRY gene in patients with mixed gonadal dysgenesis. Ann Genet 2001;44:155–159.
19.
Álvarez-Nava F, Soto M, Sánchez MA, Fernández E, Lanes R: Molecular analysis in Turner syndrome. J Pediatr 2003;142:336–340.
20.
Delgado W, Rojas Martínez A, Ortiz R, Martínez C, Rojas-Atencio A, Quintero M, et al: Del (1) (q23) in a patient with Hutchinson-Gilford progeria. Am J Med Genet 2002;113:298–301.
21.
Delgado-Luengo W, Hernández-Rodríguez ML, Valbuena-Pirela I, Gonzále- Ferrer, S, Estrada-Corona P, Chacón-Fonseca I, et al: Human disorganization complex, as a polytopic blastogenesis defect: A new case. Am J Med Genet 2004;125A:181–185.
22.
Restrepo CM, Pineda L, Rojas-Martinez A, Gutierrez CA, Morales A, Gómez Y, et al: CFTR mutations in three Latin American countries. Am J Med Genet 2000;91:277–279.
23.
Pineda-Bernal L, Borjas-Fajardo L, Zabala W, Fernandez E, Delgado W, Salas A, Sanchez- Diz P, Carracedo A: Data for nine autosomal STRs markers (CSF1PO, D13S31, D16S539, D7S820, F13A01, FESFPS, TH01, vWA, TPOX) from Venezuela. Forensic Sci Int 2002;125:277–278.
24.
Pineda Bernal L, Rodriguez A, Lareu MV, Carracedo A, Barral S, Borjas-Fajardo L: Behavior of loci D1S1656 and D12S391 in a sample from Maracaibo, Venezuela. Am J Hum Biol 2003;15:68–71.
25.
Molero AE, Pino-Ramirez G, Maestre GE: Modulation by age and gender of risk for Alzheimer’s disease and vascular dementia associated with the apolipoprotein E-varepsilon4 allele in Latin Americans: Findings from the Maracaibo Aging Study. Neurosci Lett 2001;307:5–8.
26.
Tudares C, Villalobos H: Determination of vanadium concentration in foods produced on the eastern coast of Lake Maracaibo (in Spanish). Invest Clin 1998;39(suppl 1):29–38.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.